Canadian Cancer Society: Health Equity Research Grants 2022


Canadian Cancer Society (CCS)


Advancing a more accessible and inclusive cancer care system

For More Information

For additional information, please visit the Canadian Cancer Society website for

  • Program guidelines
  • Application forms
  • Evaluation criteria


The purpose of this funding program is to support research projects that seek to advance cancer-related health equity. Projects must be collaborative, co-created by people both affected by cancer and by structural marginalization, and designed to address the systemic, structural, and institutional factors that sustain health disparities in Canada. Applications should take a social determinants of health perspective in identifying and defining both the health equity need and the community of focus, taking care to consider the intersectionalities of such communities.


Research teams will be comprised of relevant partners as integral members of the team from the outset:

  • A Principal Investigator who meets the eligibility criteria, and who brings with them an authentic, demonstrated commitment to health equity research. Researchers that have not traditionally worked in cancer, but are focused on health equity research (e.g. social scientists, arts-based researchers, community-engaged researchers) are encouraged to apply. For applications involving First Nations, Inuit and Métis Peoples, the Principal Investigator or co-Principal Investigator must self-identify as Indigenous or engage (an) Indigenous Elder(s) or Knowledge Keeper(s) to provide evidence of meaningful and culturally safe engagement with Indigenous communities.
  • A team (Principal Investigator, Co-Principal Investigator(s), Co-Applicant(s), People affected by cancer, Implementers and Decision-makers, Additional Authors and Collaborators) whose clear focus is on health equity, and who collectively bring the appropriate experience and expertise to bear towards achieving the research objectives. Health equity training may be required for some members of the research team (e.g. trainees) and should be described where needed.
  • People affected by cancer are people both affected by structural marginalization and at risk of cancer, patients, survivors, and/or caregivers. These individuals must be integrally involved in co-creating all aspects of the research plan from the outset, beginning with the identification of a research issue of importance and relevance, through to dissemination of results. The characteristics and intersections of sub-populations should be carefully considered to ensure fair representation. Teams may consult the CIHR Strategy for Patient-Oriented Research – Patient Engagement Framework for guidance on meaningful engagement.
  • Implementers and decision-makers include professionals (healthcare, community-based, administrators, policy makers) who may be involved in implementing the proposed approaches to enhance health equity. These individuals must be integrally involved in the project from the outset and must demonstrate their commitment to the proposed work.
  • A detailed Terms of Reference (that can evolve over the project) for all members of the team will be required as part of the application process and regular check-ins by CCS staff throughout the duration of funding will confirm appropriate engagement of stakeholders.

Review eligibility and requirements 

Funding Availability

Up to $3M total over 3 years for this funding program

Maximum Project Value

Up to $300k per grant (max $150k/yr)

Indirect Costs


Project Duration

Over 2–3 years

Special Notes


Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.


If College-level review is required, your College will communicate its earlier internal deadlines.

External Deadline

Abstract Registration (Mandatory):  Applicant to apply and submit abstract using on line application system EGrAMS

Please review the attached application guide prior to submitting your abstract. 

Abstract registration includes: 

  1. Applicant details (Principal Investigator (PI), Co-PIs, Co-Applicants, Additional Authors, People affected by cancer, Implementers/Decision-makers, and Collaborators) 
  2. A scientific abstract that describes the rationale, overall aims/objectives, methods, and anticipated outcomes of the project.
  3. Keywords 
  4. A relevance statement that clearly explains the rationale for the population of focus (including sub-groups and intersectionality of determinants) and the chosen approach to advance cancer-related health equity. Meaningful, integral involvement of relevant representatives in identifying the proposed topic, study design and methods, evaluation/analysis and dissemination plans must be evident. Implications and proposed methods for achieving outcomes should be described.  
  5. Suggested reviewers 
  6. Research tracking information 


Internal Deadline

Application (If Invited): Applicant to submit a copy of application along with a complete OR5 form to:

External Deadline

Application (If Invited): Applicant to apply and submit application using on line application system EGrAMS

Please review the attached application guide prior to submitting your application. When preparing the full application, the following additional information is required:

  1. Public summary 
  2. A detailed proposal (up to 5 pages) including overall goal and aims of the project, supporting evidence/rationale, guiding theoretical framework, study design, methods, and evaluation/analysis (including alternative approaches should initial plans fail) and how risks (including potential harms to communities) will be mitigated. Details of data ownership (e.g. OCAP® Principles for First Nations) should be described. Details of the team members including how all team members have been and will be integrated into the work proposed must be included. Briefly describe how patient/survivor/caregiver and implementer/decision-maker stakeholders were recruited to the team, including whether relationships preceded the funding opportunity announcement. Inclusion of accessibility, equity, diversity and inclusion principles in the composition of the research team must be evident. A description of the research environment where the work will take place is also required. An additional 2 pages of figures/tables/charts and associated legends are permitted. 
  3. A description of how sex and/or gender and/or dimensions of diversity/determinants of health and their intersectionalities have been factored into the study design. While this section is called out in the application here, it should represent a fundamental component of the research proposal given the nature of this competition. 
  4. Terms of Reference for all team members. 
  5. A description of products or programs anticipated to result from this research, including details of ownership and a clear dissemination (and implementation) plan. Include dissemination methodology/tactics to stakeholder communities.
  6. A detailed budget and justification providing rationale for the requested consumables, personnel (including team members, where eligible), and equipment associated with the research project. Consult SPOR guidance, CCS policy or contact CCS for additional information on remuneration eligibility. 


For Questions, please contact

Contact CCS research staff at 

Office of Research

Ornella McCarron, Grants Officer
Research Services Office
519-824-4120 x52832

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences